Suchergebnisse - "Matsuura, Kentaro"

PubPharm (222)

1

Efficacy of antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Kawamura, H. | Matsuura, K. | Ito, K. | +5

2

Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation

enthalten in: Journal of gastroenterology | 2024

von Uojima, H. | Yamasaki, K. | Sugiyama, M. | +25

3

Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Suzuki, T. | Matsuura, K. | Imura, N. | +7

4

Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma

enthalten in: Journal of gastroenterology and hepatology | 2024

von Toyoda, H. | Tada, T. | Uojima, H. | +22

5

Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma : A multicenter study

enthalten in: Oncology | 2024

von Suzuki, T. | Matsuura, K. | Suzuki, Y. | +19

6

Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Toyoda, H. | Kanneganti, M. | Melendez-Torres, J. | +34

7

New quantitative measurement system for M2BPGi reveals liver inflammation complicates liver cirrhosis diagnosis

enthalten in: ResearchSquare.com | 2024

von Uojima, H. | Yamasaki, K. | Sugiyama, M. | +25

8

Serum angiopoietin-2 levels predict the development of hepatocellular carcinoma following hepatitis C virus eradication using direct-acting antiviral agents

enthalten in: Oncology | 2024

von Suzuki, T. | Matsuura, K. | Nagura, Y. | +8

9

Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Nagura, Y. | Suzuki, T. | Matsuura, K. | +10

10

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma : A multicenter analysis

enthalten in: Cancer Medicine | 2024

von Suzuki, T. | Matsuura, K. | Suzuki, Y. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]